Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Relief for Shire as FDA clears NPS’ Natpara

Drug was a key interest as part of NPS takeover

- PMLiVE

Grayling CEO Pete Pedersen resigns

He steps down after two years in role at Huntsworth company

- PMLiVE

Boehringer and Lilly sway NICE with new Jardiance data

Diabetes drug now backed to help glycaemic control in adults

- PMLiVE

Sharing the ‘chimp’ and its effect on decision-making

Pharma needs to learn how to dial up its emotional connectivity

- PMLiVE

GSK set ‘to cut 1,000 jobs’ in China

Pharma company's troubles in the country reportedly continue

EU flag

Antibiotics among 7 new drugs backed by EMA

The Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

- PMLiVE

CHMP thumbs up for Novo’s obesity drug Saxenda

Diabetes drug liraglutide on course for new indication in EU

- PMLiVE

FDA panel backs new antifungal Cresemba

Basilea/Astellas drug tipped to become a $500m product

- PMLiVE

NICE heart attack recommendation for Xarelto

Bayer drug on course for another blood clot indication in England and Wales

Pfizer strikes genetic research deal with 23andMe

Lupus study and research community forms just one part of their collaboration

- PMLiVE

Havas Group acquires German comms agency Bird & Schulte

Freiburg-based firm will now operate as Havas Life Bird & Schulte

- PMLiVE

Pharma can learn to invent like an entrepreneur

Why pharma firms don’t always have to behave like corporations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links